Cargando…
Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial
Nelonemdaz is a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, as proven in preclinical ischemia-reperfusion studies. We aimed to evaluate the safety and efficacy of nelonemdaz in patients with acute ischemic stroke receiving endovascu...
Autores principales: | Hong, Ji Man, Lee, Jin Soo, Lee, Yeong-Bae, Shin, Dong Hoon, Shin, Dong-Ick, Hwang, Yang-Ha, Ahn, Seong Hwan, Kim, Jae Guk, Sohn, Sung-Il, Kwon, Sun U., Lee, Ji Sung, Gwag, Byoung Joo, Chamorro, Ángel, Choi, Dennis W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586831/ https://www.ncbi.nlm.nih.gov/pubmed/36065810 http://dx.doi.org/10.1161/STROKEAHA.122.039649 |
Ejemplares similares
-
The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy
por: Lee, Jin Soo, et al.
Publicado: (2023) -
Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial
por: Hong, Ji Man, et al.
Publicado: (2018) -
Futile reperfusion and predicted therapeutic benefits after successful endovascular treatment according to initial stroke severity
por: Lee, Sang-Hwa, et al.
Publicado: (2019) -
Factors Contributing to an Efficacious Endovascular Treatment for Acute Ischemic Stroke in Asian Population
por: Lee, Jin Soo, et al.
Publicado: (2021) -
Endovascular Reperfusion Therapy in Minor Stroke with Neurologic Deterioration beyond 24 Hours from Onset
por: Lee, Min A, et al.
Publicado: (2023)